These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17225261)

  • 1. New risks with newer rheumatoid arthritis drugs.
    Mayo Clin Health Lett; 2006 Nov; 24(11):4. PubMed ID: 17225261
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs for rheumatoid arthritis.
    Olsen NJ; Stein CM
    N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
    [No Abstract]   [Full Text] [Related]  

  • 3. Morbidity and mortality in rheumatoid patients during treatment with adalimumab and infliximab.
    Molloy E; Ramakrishnan S; Murphy E; Barry M
    Rheumatology (Oxford); 2004 Apr; 43(4):522-3. PubMed ID: 15024136
    [No Abstract]   [Full Text] [Related]  

  • 4. Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm data.
    Keystone EC
    J Rheumatol; 2011 Aug; 38(8):1552-62. PubMed ID: 21572154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
    Nagashima T; Minota S
    J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
    [No Abstract]   [Full Text] [Related]  

  • 6. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute generalized skin eruption due to adalimumab: report of two cases.
    Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
    [No Abstract]   [Full Text] [Related]  

  • 8. Dermatomyositis during adalimumab therapy for rheumatoid arthritis.
    Brunasso AM; Scocco GL; Massone C
    J Rheumatol; 2010 Jul; 37(7):1549-50. PubMed ID: 20595297
    [No Abstract]   [Full Text] [Related]  

  • 9. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab.
    Bassetti M; Pizzorni C; Gradoni L; Del Bono V; Cutolo M; Viscoli C
    Rheumatology (Oxford); 2006 Nov; 45(11):1446-8. PubMed ID: 16887847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cutaneous rash from the use of medicine for rheumatoid arthritis].
    Hannuksela M
    Duodecim; 2006; 122(1):105, 111. PubMed ID: 16509198
    [No Abstract]   [Full Text] [Related]  

  • 11. Adalimumab-induced pityriasis rosea.
    Rajpara SN; Ormerod AD; Gallaway L
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1294-6. PubMed ID: 17894747
    [No Abstract]   [Full Text] [Related]  

  • 12. Adalimumab-induced lupus erythematosus.
    Al-Niaimi F
    Eur J Dermatol; 2009; 19(4):380. PubMed ID: 19451046
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
    Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
    Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
    [No Abstract]   [Full Text] [Related]  

  • 14. Adalimumab-induced cutaneous lupus.
    Sheth N; Greenblatt D; Patel S; Acland K
    Clin Exp Dermatol; 2007 Sep; 32(5):593-4. PubMed ID: 17692063
    [No Abstract]   [Full Text] [Related]  

  • 15. Adalimumab-associated pulmonary fibrosis reply.
    Huggett MT; Armstrong R
    Rheumatology (Oxford); 2007 Aug; 46(8):1379-80; author reply 1379. PubMed ID: 17553912
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous lupus erythematosus induced by adalimumab.
    Vezzoli P; Violetti SA; Serini SM; Muratori S; Berti E; Crosti C
    J Dermatol; 2011 Mar; 38(3):283-4. PubMed ID: 21342233
    [No Abstract]   [Full Text] [Related]  

  • 17. Adalimumab-induced asthma.
    Bennett AN; Wong M; Zain A; Panayi G; Kirkham B
    Rheumatology (Oxford); 2005 Sep; 44(9):1199-200. PubMed ID: 15870147
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis.
    Giles JT; Bartlett SJ; Gelber AC; Nanda S; Fontaine K; Ruffing V; Bathon JM
    Arthritis Rheum; 2006 Apr; 55(2):333-7. PubMed ID: 16583385
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of varicella during adalimumab therapy.
    Lee DH; Kim HS; Song YW; Cho KH
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):687-8. PubMed ID: 17447988
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis].
    Tomono K; Hashimoto S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():573-8. PubMed ID: 15799420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.